Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Progressive High-grade Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07544992
What this trial is testing

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma, IDH-Wildtype
City of Hope Medical Center 24
Early research (Phase 1)Study completedNCT00087451
What this trial is testing

Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)

Who this might be right for
Malignant GliomaGlioblastomaGliosarcoma
Merck Sharp & Dohme LLC 11
Early research (Phase 1)Study completedNCT00107458
What this trial is testing

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 26
Testing effectiveness (Phase 2)Study completedNCT03557359
What this trial is testing

Nivolumab for Recurrent or Progressive IDH Mutant Gliomas

Who this might be right for
Gliomas
Fabio Iwamoto, MD 35
Testing effectiveness (Phase 2)Study completedNCT00275002
What this trial is testing

O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT02026271
What this trial is testing

Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic Oligoastrocytoma
Alaunos Therapeutics 40
Early research (Phase 1)Study completedNCT00017264
What this trial is testing

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07301268
What this trial is testing

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Who this might be right for
Glioblastoma, IDH-WildtypeProgressive Astrocytoma, IDH-Mutant, Grade 4Progressive Glioblastoma+6 more
Mayo Clinic 36
Testing effectiveness (Phase 2)Looking for participantsNCT05278208
What this trial is testing

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Who this might be right for
High Grade GliomaMeningiomaEmbryonal Tumor+10 more
Nationwide Children's Hospital 65
Early research (Phase 1)Looking for participantsNCT07551336
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Who this might be right for
Malignant GliomaHigh-Grade GliomasGlioblastoma+2 more
Beijing Biotech 36
Early research (Phase 1)Study completedNCT00100880
What this trial is testing

Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+23 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Ended earlyNCT01189240
What this trial is testing

RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT00079092
What this trial is testing

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Wake Forest University Health Sciences 18
Early research (Phase 1)Looking for participantsNCT07480941
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Who this might be right for
GlioblastomaHigh-grade GliomaMalignant Glioma+2 more
Beijing Biotech 36
Early research (Phase 1)Not Yet RecruitingNCT07331064
What this trial is testing

Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor

Who this might be right for
High Grade GliomasAtypical Teratoid Rhabdoid Tumors (ATRT)Diffuse Midline Glioma+2 more
Sarah Rumler 15
Early research (Phase 1)Not Yet RecruitingNCT06737146
What this trial is testing

Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma

Who this might be right for
High-grade Glioma
Suzhou Maximum Bio-tech Co., Ltd. 12
Early research (Phase 1)Active Not RecruitingNCT02359565
What this trial is testing

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeLynch SyndromeMalignant Glioma+8 more
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Study completedNCT00047281
What this trial is testing

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Dana-Farber Cancer Institute
Very early researchEnded earlyNCT02500459
What this trial is testing

Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection

Who this might be right for
Brain TumorHigh Grade Glioma
Michael Vogelbaum, MD, PhD 9
Early research (Phase 1)Study completedNCT00098761
What this trial is testing

VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 42
Next Page